505 related articles for article (PubMed ID: 30514193)
21. Survival Difference in Patients with Malignant Pleural Effusions Treated with Pleural Catheter or Talc Pleurodesis.
Liou DZ; Serna-Gallegos D; Chan JL; Borgella J; Akhmerov S; Soukiasian HJ
Am Surg; 2016 Oct; 82(10):995-999. PubMed ID: 27779992
[TBL] [Abstract][Full Text] [Related]
22. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
24. Malignant Pleural Effusion: Diagnosis and Management.
Ferreiro L; Suárez-Antelo J; Álvarez-Dobaño JM; Toubes ME; Riveiro V; Valdés L
Can Respir J; 2020; 2020():2950751. PubMed ID: 33273991
[TBL] [Abstract][Full Text] [Related]
25. [The treatment of malignant pleural effusions: the experience of a multidisciplinary thoracic endoscopy group].
Bertolaccini L; Zamprogna C; D'Urso A; Massaglia F
Tumori; 2003; 89(4 Suppl):233-6. PubMed ID: 12903603
[TBL] [Abstract][Full Text] [Related]
26. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.
Suzuki K; Servais EL; Rizk NP; Solomon SB; Sima CS; Park BJ; Kachala SS; Zlobinsky M; Rusch VW; Adusumilli PS
J Thorac Oncol; 2011 Apr; 6(4):762-7. PubMed ID: 21325982
[TBL] [Abstract][Full Text] [Related]
27. Multidisciplinary management of malignant pleural effusion.
Kaifi JT; Toth JW; Gusani NJ; Kimchi ET; Staveley-O'Carroll KF; Belani CP; Reed MF
J Surg Oncol; 2012 Jun; 105(7):731-8. PubMed ID: 21960207
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
Psallidas I; Kanellakis NI; Gerry S; Thézénas ML; Charles PD; Samsonova A; Schiller HB; Fischer R; Asciak R; Hallifax RJ; Mercer R; Dobson M; Dong T; Pavord ID; Collins GS; Kessler BM; Pass HI; Maskell N; Stathopoulos GT; Rahman NM
Lancet Oncol; 2018 Jul; 19(7):930-939. PubMed ID: 29908990
[TBL] [Abstract][Full Text] [Related]
29. Outpatient talc administration via indwelling pleural catheters for malignant effusions.
Dipper A; Bhatnagar R; Maskell N
Curr Opin Pulm Med; 2019 Jul; 25(4):380-383. PubMed ID: 30998600
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Factors of 30-Day Mortality After Palliative Procedures in Patients with Malignant Pleural Effusion.
Abrao FC; de Abreu IR; Fogarolli M; Caxeiro G; Bezerra CB; de Cerqueira Cesar FP; Rocha PS; Younes RN
Ann Surg Oncol; 2015 Nov; 22(12):4083-8. PubMed ID: 25758190
[TBL] [Abstract][Full Text] [Related]
31. Management of Malignant Pleural Effusions-What Is New.
Thomas R; Roy B; Maldonado F; Lee YCG
Semin Respir Crit Care Med; 2019 Jun; 40(3):323-339. PubMed ID: 31525808
[TBL] [Abstract][Full Text] [Related]
32. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
[TBL] [Abstract][Full Text] [Related]
33. [Management of Malignant Pleural Effusion].
Larisch C; Riedel J; Hofmann HS; Ried M
Zentralbl Chir; 2024 Jun; 149(3):315-327. PubMed ID: 38838699
[TBL] [Abstract][Full Text] [Related]
34. Comparing approaches to the management of malignant pleural effusions.
Porcel JM; Lui MM; Lerner AD; Davies HE; Feller-Kopman D; Lee YC
Expert Rev Respir Med; 2017 Apr; 11(4):273-284. PubMed ID: 28271728
[TBL] [Abstract][Full Text] [Related]
35. Management of malignant pleural effusion associated with trapped lung syndrome.
Qureshi RA; Collinson SL; Powell RJ; Froeschle PO; Berrisford RG
Asian Cardiovasc Thorac Ann; 2008 Apr; 16(2):120-3. PubMed ID: 18381869
[TBL] [Abstract][Full Text] [Related]
36. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
37. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
38. Early and late mortality after pleurodesis for malignant pleural effusion.
Bernard A; de Dompsure RB; Hagry O; Favre JP
Ann Thorac Surg; 2002 Jul; 74(1):213-7. PubMed ID: 12118761
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.
Cardillo G; Facciolo F; Carbone L; Regal M; Corzani F; Ricci A; Di Martino M; Martelli M
Eur J Cardiothorac Surg; 2002 Feb; 21(2):302-5; discussion 305-6. PubMed ID: 11825740
[TBL] [Abstract][Full Text] [Related]
40. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
